Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of Recurrent and De Novo NAFLD/NASH After Liver Transplantation
Giacomo Germani, Marie Laryea, Laura Rubbia‐Brandt, et al.
Transplantation (2018) Vol. 103, Iss. 1, pp. 57-67
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management
Thomas Marjot, Ahmad Moolla, Jeremy Cobbold, et al.
Endocrine Reviews (2019) Vol. 41, Iss. 1, pp. 66-117
Open Access | Times Cited: 191
NAFLD and liver transplantation: Disease burden, current management and future challenges
Patrizia Burra, Chiara Becchetti, Giacomo Germani
JHEP Reports (2020) Vol. 2, Iss. 6, pp. 100192-100192
Open Access | Times Cited: 180
Nonalcoholic Steatohepatitis After Liver Transplantation
Thomas G. Cotter, Michael Charlton
Liver Transplantation (2019) Vol. 26, Iss. 1, pp. 141-159
Closed Access | Times Cited: 76
Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025
Elke Roeb, Ali Canbay, Frank Tacke, et al.
Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 09, pp. 1346-1421
Open Access | Times Cited: 53
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)
Ajay Duseja, Shivaram Prasad Singh, Arka De, et al.
Journal of Clinical and Experimental Hepatology (2022) Vol. 13, Iss. 2, pp. 273-302
Open Access | Times Cited: 47
Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation
Amedeo Lonardo, Alessandro Mantovani, Salvatore Petta, et al.
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 10, pp. 638-650
Closed Access | Times Cited: 42
Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy
Jihao Xu, Yifan Li, Zhaolan Feng, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 221-221
Open Access | Times Cited: 1
Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
Sara Battistella, Francesca D’Arcangelo, Marco Grasso, et al.
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S286-S301
Open Access | Times Cited: 32
S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)
Thomas Berg, Niklas Aehling, Tony Bruns, et al.
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 09, pp. 1397-1573
Closed Access | Times Cited: 7
Management of metabolic syndrome and cardiovascular risk after liver transplantation
Evangelia Fatourou, Emmanuel Tsochatzis
˜The œLancet. Gastroenterology & hepatology (2019) Vol. 4, Iss. 9, pp. 731-741
Open Access | Times Cited: 43
Factors Impacting Survival in Those Transplanted for NASH Cirrhosis: Data From the NailNASH Consortium
Mary E. Rinella, Sanjaya K. Satapathy, Danielle Brandman, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 21, Iss. 2, pp. 445-455.e2
Closed Access | Times Cited: 23
Vagus Nerve Mediated Liver-Brain-Axis Is a Major Regulator of the Metabolic Landscape in the Liver
Camila F. Brito, Roberta Cristelli Fonseca, Lucas Rodrigues‐Ribeiro, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2166-2166
Open Access
Metabolic associated fatty liver disease: Addressing a new era in liver transplantation
Madeleine Gill, Avik Majumdar
World Journal of Hepatology (2020) Vol. 12, Iss. 12, pp. 1168-1181
Open Access | Times Cited: 38
Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) – April 2022 – AWMF Registration No.: 021–025

Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 09, pp. e733-e801
Open Access | Times Cited: 21
Genetic Risk Factors for Steatotic Liver Disease After Liver Transplantation
Ville Liukkonen, Maria Semenova, Kati Hyvärinen, et al.
Liver International (2025) Vol. 45, Iss. 4
Closed Access
Challenges in the management of MetALD after liver transplantation
M. Cucco, Chiara Becchetti, Miki Scaravaglio, et al.
Metabolism and Target Organ Damage (2025) Vol. 5, Iss. 1
Open Access
Recurrence of hepatocellular carcinoma following liver transplantation
Daniel Hoffman, Neil Mehta
Expert Review of Gastroenterology & Hepatology (2020) Vol. 15, Iss. 1, pp. 91-102
Closed Access | Times Cited: 31
Metabolic Consequences of Solid Organ Transplantation
Mamatha Bhat, S.E. Usmani, Amirhossein Azhie, et al.
Endocrine Reviews (2020) Vol. 42, Iss. 2, pp. 171-197
Open Access | Times Cited: 31
Mechanisms of nonalcoholic fatty liver disease and implications for surgery
Benedikt Kaufmann, Agustina Reca, Baocai Wang, et al.
Langenbeck s Archives of Surgery (2020) Vol. 406, Iss. 1, pp. 1-17
Open Access | Times Cited: 30
Nonalcoholic steatohepatitis recurrence after liver transplant
Sunil Taneja, Akash Roy
Translational Gastroenterology and Hepatology (2020) Vol. 5, pp. 24-24
Open Access | Times Cited: 29
Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease
Avik Majumdar, Emmanuel Tsochatzis
Metabolism (2020) Vol. 111, pp. 154291-154291
Open Access | Times Cited: 28
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
Giulio Marchesini, Elisabetta Bugianesi, Patrizia Burra, et al.
Digestive and Liver Disease (2021) Vol. 54, Iss. 2, pp. 170-182
Open Access | Times Cited: 25
Non-alcoholic fatty liver disease: Current therapeutic options
Avik Majumdar, Jef Verbeek, Emmanuel Tsochatzis
Current Opinion in Pharmacology (2021) Vol. 61, pp. 98-105
Open Access | Times Cited: 24
Fatty Liver Through the Ages: Nonalcoholic Steatohepatitis
Zobair M. Younossi, Linda Henry
Endocrine Practice (2021) Vol. 28, Iss. 2, pp. 204-213
Closed Access | Times Cited: 24
Lactobacillus reuteri MJM60668 Prevent Progression of Non-Alcoholic Fatty Liver Disease through Anti-Adipogenesis and Anti-Inflammatory Pathway
Pia Werlinger, Huong Thi Nguyen, Mingkun Gu, et al.
Microorganisms (2022) Vol. 10, Iss. 11, pp. 2203-2203
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top